How big is the drug screening industry?

The global drug screening market size is expected to increase USD 39.32 billion by 2034 from USD 7.82 billion in 2023. Read More

What is the growth rate of the drug screening industry?

The global drug screening market will register growth rate of 15.8% between 2024 and 2034. Read More

Who are the prominent players operating in the drug screening market?

The major players operating in the drug screening market are Quest Diagnostics Incorporated, Abbott Laboratories, Quidel Corporation, F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., LabCorp, Drgerwerk AG & CO. KGaA, Clinical Reference Laboratory (CRL), Inc., Cordant Health Solutions, Legacy Medical Services, LLC, Omega Laboratories, Inc., and Others. Read More

Which are the driving factors of the drug screening market?

The driving factors of the drug screening market are the requirement of early detection and fuelled demand for novel therapeutics. Read More

Which region will lead the global drug screening market?

North America region will lead the global drug screening market during the forecast period 2024 to 2034. Read More

Drug Screening Market Size, Share, and Trends 2024 to 2034

Drug Screening Market (By Product And Service: Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service; By Sample Type: Urine Sample, Breath Sample, Oral Fluid Sample, Hair Sample, Others Sample; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034

Last Updated : August 2024
Report Code : 4169
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Drug Screening Market

5.1. COVID-19 Landscape: Drug Screening Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Drug Screening Market, By Product And Service

8.1. Drug Screening Market Revenue and Volume, by Product And Service, 2024-2034

8.1.1 Drug Screening Product

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Analytical Instruments

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Rapid Testing Devices

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. Oral Fluid Testing Devices

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

8.1.5. Consumables

8.1.5.1. Market Revenue and Volume Forecast (2021-2034)

8.1.6. Drug Screening Service

8.1.6.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Drug Screening Market, By Sample Type

9.1. Drug Screening Market Revenue and Volume, by Sample Type, 2024-2034

9.1.1. Urine Sample

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Breath Sample

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Oral Fluid Sample

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

9.1.4. Hair Sample

9.1.4.1. Market Revenue and Volume Forecast (2021-2034)

9.1.5. Others Sample

9.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Drug Screening Market, By End-user

10.1. Drug Screening Market Revenue and Volume, by End-user, 2024-2034

10.1.1. Drug Testing Labs

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Workplaces

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Criminal Justice and Law Enforcements Agencies

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Hospitals

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

10.1.5. Drug Treatment Centre

10.1.5.1. Market Revenue and Volume Forecast (2021-2034)

10.1.6. Individual Users

10.1.6.1. Market Revenue and Volume Forecast (2021-2034)

10.1.7. Pain Management Centre

10.1.7.1. Market Revenue and Volume Forecast (2021-2034)

10.1.8. Schools And Colleges

10.1.8.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Drug Screening Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product And Service (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Sample Type (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by End-user (2021-2034)

Chapter 12. Company Profiles

12.1. Quest Diagnostics Incorporated

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Abbott Laboratories

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Quidel Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. F. Hoffmann-La Roche

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Thermo Fisher Scientific, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Siemens Healthineers

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Bio-Rad Laboratories, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Agilent Technologies, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. LabCorp

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Drgerwerk AG & CO. KGaA

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

We use cookies to improve your experience

Drug Screening Market Size to Hit USD 39.32 Bn by 2034

List of Contents